Related Experiment Video
Updated: Apr 17, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding
1Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
Abstract:
Destabilized mutant p53s coaggregate with WT p53, p63, and p73 in cancer cell lines. We found that stoichiometric amounts of aggregation-prone mutants induced only small amounts of WT p53 to coaggregate, and preformed aggregates did not significantly seed the aggregation of bulk protein. Similarly, p53 mutants trapped only small amounts of p63 and p73 into their p53 aggregates. Tetrameric full-length protein aggregated at similar rates and kinetics to isolated core domains, but there was some induced aggregation of WT by mutants in hetero-tetramers. p53 aggregation thus differs from the usual formation of amyloid fibril or prion aggregates where tiny amounts of preformed aggregate rapidly seed further aggregation. The proposed aggregation mechanism of p53 of rate-determining sequential unfolding and combination of two molecules accounts for the difference. A molecule of fast-unfolding mutant preferentially reacts with another molecule of mutant and only occasionally traps a slower unfolding WT molecule. The mutant population rapidly self-aggregates before much WT protein is depleted. Subsequently, WT protein self-aggregates at its normal rate. However, the continual production of mutant p53 in a cancer cell would gradually trap more and more WT and other proteins, accounting for the observations of coaggregates in vivo. The mechanism corresponds more to trapping by cross-reaction and coaggregation rather than classical seeding and growth.
Insights
Mutant p53 proteins coaggregate with wild-type p53 and related proteins in cancer cells. This aggregation mechanism involves trapping rather than classical seeding, explaining p53
Area of Science:
- Molecular Biology
- Cancer Biology
- Protein Biochemistry
Background:
- Mutations in tumor suppressor protein p53 are common in cancer.
- p53 family members (p63, p73) share structural similarities with p53.
- Protein aggregation is implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the aggregation behavior of mutant p53 proteins.
- To determine if mutant p53 coaggregates with wild-type (WT) p53 and p53 family members.
- To elucidate the mechanism of p53 aggregation in cancer.
Main Methods:
- Utilized cancer cell lines expressing destabilized p53 mutants.
- Analyzed co-aggregation of mutant p53 with WT p53, p63, and p73.
- Compared aggregation kinetics of full-length tetrameric p53 with isolated core domains.
Main Results:
- Destabilized mutant p53 proteins coaggregate with WT p53, p63, and p73 in cancer cell lines.
- Mutant p53 primarily self-aggregates, with limited trapping of WT p53, p63, and p73.
- p53 aggregation mechanism differs from classical seeding, involving sequential unfolding and cross-reaction.
Conclusions:
- Mutant p53 aggregation in cancer is characterized by trapping and co-aggregation, not seeding.
- The continuous production of mutant p53 in cancer cells can lead to gradual trapping of WT p53 and other proteins.
- Understanding p53 aggregation mechanisms is crucial for developing targeted cancer therapies.
More Related Videos
11:37Generation of Aggregates of Mouse Embryonic Stem Cells that Show Symmetry Breaking, Polarization and Emergent Collective Behaviour In Vitro
Published on: November 24, 2015
04:47Measuring Transcellular Interactions through Protein Aggregation in a Heterologous Cell System
Published on: May 22, 2020